Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience

Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience

Backgrounds: A recent randomized control trial (JCOG1202; ASCOT trial) demonstrated the efficacy of adjuvant S-1 chemotherapy (ASC) for biliary tract cancer (BTC) after surgical resection; however, the significance of the completion of ASC in the real-world setting remains unknown. Methods: Data of...

Full description

Bibliographic Details
Main Authors: Kentaro Iwaki, Tomoaki Yoh, Hiroto Nishino, Takahiro Nishio, Yukinori Koyama, Satoshi Ogiso, Takamichi Ishii, Masashi Kanai, Etsuro Hatano
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Asian Journal of Surgery
Subjects:
Biliary tract cancer
Adjuvant chemotherapy
S-1
Treatment failure
Adverse effects
Completion rate
Online Access:http://www.sciencedirect.com/science/article/pii/S1015958423020833

Internet

http://www.sciencedirect.com/science/article/pii/S1015958423020833

Similar Items